FNDC4 and colorectal cancer: For FNDC4, differential expression was not detected in colorectal cancer tissues but increased in inflammatory bowel disease samples.[4] Similar to previously reported results in other studies, the majority of malignancies in our analysis had decreased mRNA expression.